Disparities in treatment and outcome of kidney replacement therapy in children with comorbidities: an ESPN/ERA Registry study
Related Experiment Video
Updated: Aug 4, 2025

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Raphael Schild1, Simeon Dupont1, Jérôme Harambat2
1Division of Pediatric Nephrology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Insights
Comorbidities are increasingly common in children undergoing kidney replacement therapy (KRT), negatively impacting their transplant access and survival, particularly for those on dialysis. Addressing these comorbidities is crucial for improving outcomes in pediatric kidney patients.
Area of Science:
- Pediatric Nephrology
- Renal Replacement Therapy
- Comorbidity Research
Background:
- Limited data exists on comorbidities in children receiving kidney replacement therapy (KRT).
- Comorbidities significantly influence prognosis and treatment strategies in pediatric kidney disease.
- This study addresses the scarcity of information by analyzing comorbidity prevalence and impact in European children on KRT.
Purpose of the Study:
- To determine the prevalence of comorbidities in European children starting KRT.
- To investigate the impact of comorbidities on kidney transplantation (KT) access and patient survival.
- To analyze differences in comorbidity prevalence and outcomes based on country income levels.
Main Methods:
- Retrospective analysis of data from 4127 children (<20 years) commencing KRT between 2007-2017.
- Data sourced from the European Society of Paediatric Nephrology/European Renal Association Registry across 22 European countries.
- Cox regression models used to compare KT access, patient survival, and graft survival between children with and without comorbidities.
Main Results:
- Comorbidities were present in 33% of children starting KRT, with an annual prevalence increase of 5%.
- Children with comorbidities had reduced KT access (aHR 0.67) and increased mortality risk (aHR 1.79), especially those on dialysis.
- The impact of comorbidities on mortality was more pronounced in low-income countries; graft survival was unaffected.
Conclusions:
- Comorbidities are increasingly prevalent in pediatric KRT patients, hindering transplant access and survival.
- Kidney transplantation should be prioritized for all pediatric KRT patients, including those with comorbidities.
- Identifying and addressing modifiable barriers to KT for children with comorbidities is essential.
Background:
Data on comorbidities in children on kidney replacement therapy (KRT) are scarce. Considering their high relevance for prognosis and treatment, this study aims to analyse the prevalence and implications of comorbidities in European children on KRT.
Methods:
We included data from patients <20 years of age when commencing KRT from 2007 to 2017 from 22 European countries within the European Society of Paediatric Nephrology/European Renal Association Registry. Differences between patients with and without comorbidities in access to kidney transplantation (KT) and patient and graft survival were estimated using Cox regression.
Results:
Comorbidities were present in 33% of the 4127 children commencing KRT and the prevalence has steadily increased by 5% annually since 2007. Comorbidities were most frequent in high-income countries (43% versus 24% in low-income countries and 33% in middle-income countries). Patients with comorbidities had a lower access to transplantation {adjusted hazard ratio [aHR] 0.67 [95% confidence interval (CI) 0.61-0.74]} and a higher risk of death [aHR 1.79 (95% CI 1.38-2.32)]. The increased mortality was only seen in dialysis patients [aHR 1.60 (95% CI 1.21-2.13)], and not after KT. For both outcomes, the impact of comorbidities was stronger in low-income countries. Graft survival was not affected by the presence of comorbidities [aHR for 5-year graft failure 1.18 (95% CI 0.84-1.65)].
Conclusions:
Comorbidities have become more frequent in children on KRT and reduce their access to transplantation and survival, especially when remaining on dialysis. KT should be considered as an option in all paediatric KRT patients and efforts should be made to identify modifiable barriers to KT for children with comorbidities.
Related Concept Videos
Kidney Transplant I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention

